These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 3334613)

  • 1. Carumonam versus ceftazidime: in vitro activity, pharmacokinetics in elderly patients, safety and therapeutic efficacy in the treatment of complicated urinary tract infections.
    Naber K; Kees F; Denk K; Bauernfeind A; Grobecker H
    Chemioterapia; 1987 Jun; 6(2 Suppl):517-8. PubMed ID: 3334613
    [No Abstract]   [Full Text] [Related]  

  • 2. Carumonam in the treatment of severe and complicated urinary tract infections.
    Kotilainen P; Huovinen P; Hänninen P
    Chemioterapia; 1987 Jun; 6(2 Suppl):514-5. PubMed ID: 3509487
    [No Abstract]   [Full Text] [Related]  

  • 3. Carumonam and cefotiam in the treatment of complicated urinary tract infection (UTI): a randomized study.
    Westenfelder M; Frankenschmidt A; Pelz K
    Chemioterapia; 1987 Jun; 6(2 Suppl):515-6. PubMed ID: 3334612
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative study of Ro 17-2301 (AMA-1080) and amikacin in complicated urinary tract infections.
    Hahn LB; Iribarren M; Barclay C; Casellas J; Traballi C; Farinati A
    Chemioterapia; 1987 Jun; 6(2 Suppl):519-21. PubMed ID: 3334614
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro and in vivo experience with carumonam: a preliminary report.
    Kanellakopoulou K; Manta M; Tsagaraki C; Giamarellou H
    J Chemother; 1989 Jul; 1(4 Suppl):125. PubMed ID: 16312334
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of aztreonam in patients suffering from urinary tract infections with contraindications for the use of aminoglycosides.
    Fraschini F; Scaglione F; Alessandria M; Gattei G
    Chemioterapia; 1986 Oct; 5(5):319-21. PubMed ID: 3791478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carumonam versus ceftazidime for urinary tract infections.
    Edelstein H; Oster S; Cassano K; McCabe R
    Antimicrob Agents Chemother; 1988 Jul; 32(7):1031-3. PubMed ID: 3056245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Aztreonam: monocenter microbiological study with prevention experience in surgery].
    Malcangi A; Pesce S; Vitale M; Martinetto P
    G Batteriol Virol Immunol; 1987; 80(1-12):237-51. PubMed ID: 3509031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the therapeutic effects of aztreonam and ceftazidime in the treatment of complicated infections of the urinary tract].
    Orani A; Sala A; Spandri A; Levi L; Invernizzi S; Malagola G
    G Ital Chemioter; 1985; 32(2):443-7. PubMed ID: 3914433
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical evaluation of the combination of carumonam and fosfomycin in the treatment of complicated urinary tract infection].
    Kakizaki H; Ishii N; Murakami S; Suzuki K; Takamizawa A; Hirano J; Mitobe K; Saito M; Hirano K; Imamura A
    Hinyokika Kiyo; 1990 Jun; 36(6):731-5. PubMed ID: 2239570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Aztreonam and aminoglycosides in the therapy of urinary infections associated with renal calculosis].
    Coen G; Nazzaro L; Cipriani P; Giordano A; Mazzaferro S; Petta S; Reale MG; Smacchi A
    Clin Ter; 1989 Feb; 128(4):243-9. PubMed ID: 2524313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical efficacy of aztreonam in patients with complicated urinary tract infections].
    Yoshida K; Uchijima Y; Kobayashi N; Suwata J; Nakame Y; Saitoh H; Negishi T; Yamada T; Kageyama Y; Kura N
    Hinyokika Kiyo; 1988 Dec; 34(12):2225-32. PubMed ID: 3071130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical reevaluation of aztreonam (AZT) on urinary tract infections].
    Kohri K; Kurita T; Sakaguti H; Kadowaki T; Iguti M; Kanda H; Nagi N; Kataoka K; Kawamura M; Mitsubayashi S
    Hinyokika Kiyo; 1989 Apr; 35(4):711-6. PubMed ID: 2660527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aztreonam versus cefamandole in the treatment of urinary tract infections.
    Giamarellou H; Koratzanis G; Kanellakopoulou K; Galanakis N; Papoulias G; el Messidi M; Daikos G
    Chemioterapia; 1984 Apr; 3(2):127-31. PubMed ID: 6543431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of tigecycline monotherapy compared with vancomycin plus aztreonam in patients with complicated skin and skin structure infections: Results from a phase 3, randomized, double-blind trial.
    Sacchidanand S; Penn RL; Embil JM; Campos ME; Curcio D; Ellis-Grosse E; Loh E; Rose G
    Int J Infect Dis; 2005 Sep; 9(5):251-61. PubMed ID: 16099700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical evaluation of aztreonam for complicated urinary tract infection].
    Moriguchi R; Yamagoshi T; Nagakubo I; Aoki S
    Hinyokika Kiyo; 1985 Sep; 31(9):1675-80. PubMed ID: 4083224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative in vitro activity of carumonam with gentamicin and other beta-lactam antimicrobials: a multicentric study.
    Martín-Luengo F; Baquero F; Cisterna R; García de Lomas J; García-Rodriguez J; Gobernado M; Gómez Lus R; Perea E; Piedrola G; Roy C
    Chemioterapia; 1987 Jun; 6(2 Suppl):115-6. PubMed ID: 3334551
    [No Abstract]   [Full Text] [Related]  

  • 18. [Urinary tract infections due to multiresistant gram negative bacteria].
    Acar JF; Guibert J; Bourquelot P; Brisset JM
    Nouv Presse Med; 1974 Apr; 3(0):69-72. PubMed ID: 4209339
    [No Abstract]   [Full Text] [Related]  

  • 19. The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind phase 3 comparison studies with vancomycin-aztreonam.
    Ellis-Grosse EJ; Babinchak T; Dartois N; Rose G; Loh E; ;
    Clin Infect Dis; 2005 Sep; 41 Suppl 5():S341-53. PubMed ID: 16080072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Is aztreonam could become "a challenger" for treatment of Gram negative infections? May be an answer from microbiological data: in vitro study including 36,485 strains of enterobacteria and Pseudomonas].
    Honderlick P; Gravisse J; Dardelle D; Cahen P
    Pathol Biol (Paris); 2007 Dec; 55(10):475-7. PubMed ID: 17904768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.